Coronavirus – Nigeria: COVID-19 Household Seroprevalence Survey to study the impact of COVID-19 in Nigeria

The ongoing COVID-19 Household Seroprevalence Survey aims to better understand the burden of COVID-19 infection in the country.

Ongoing activities include household sample collection for COVID-19 testing and treatment for malaria patients diagnosed in selected states.

Distributed by APO Group on behalf of Nigeria Centre for Disease Control (NCDC).